nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloropyramine—PTK2—prostate gland—urinary bladder cancer	0.0478	0.135	CbGeAlD
Chloropyramine—PTK2—seminal vesicle—urinary bladder cancer	0.0404	0.114	CbGeAlD
Chloropyramine—PTK2—epithelium—urinary bladder cancer	0.0351	0.0994	CbGeAlD
Chloropyramine—PTK2—smooth muscle tissue—urinary bladder cancer	0.0338	0.0957	CbGeAlD
Chloropyramine—PTK2—renal system—urinary bladder cancer	0.0326	0.0922	CbGeAlD
Chloropyramine—PTK2—urethra—urinary bladder cancer	0.032	0.0905	CbGeAlD
Chloropyramine—PTK2—female reproductive system—urinary bladder cancer	0.0261	0.0738	CbGeAlD
Chloropyramine—PTK2—vagina—urinary bladder cancer	0.0236	0.0668	CbGeAlD
Chloropyramine—PTK2—lymph node—urinary bladder cancer	0.0153	0.0432	CbGeAlD
Chloropyramine—HRH1—prostate gland—urinary bladder cancer	0.0149	0.0422	CbGeAlD
Chloropyramine—HRH1—epithelium—urinary bladder cancer	0.011	0.031	CbGeAlD
Chloropyramine—HRH1—smooth muscle tissue—urinary bladder cancer	0.0106	0.0299	CbGeAlD
Chloropyramine—HRH1—urethra—urinary bladder cancer	0.00998	0.0282	CbGeAlD
Chloropyramine—HRH1—female reproductive system—urinary bladder cancer	0.00814	0.023	CbGeAlD
Chloropyramine—HRH1—vagina—urinary bladder cancer	0.00736	0.0208	CbGeAlD
Chloropyramine—Rosiglitazone—PPARG—urinary bladder cancer	0.00532	0.651	CrCbGaD
Chloropyramine—HRH1—lymph node—urinary bladder cancer	0.00476	0.0135	CbGeAlD
Chloropyramine—PTK2—Internalization of ErbB1—KRAS—urinary bladder cancer	0.0029	0.00454	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—CDH1—urinary bladder cancer	0.00289	0.00453	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—CDKN1A—urinary bladder cancer	0.00285	0.00447	CbGpPWpGaD
Chloropyramine—Clomipramine—GSTP1—urinary bladder cancer	0.00285	0.349	CrCbGaD
Chloropyramine—PTK2—EPHB forward signaling—KRAS—urinary bladder cancer	0.00284	0.00444	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—ERBB2—urinary bladder cancer	0.00281	0.0044	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—RHOA—urinary bladder cancer	0.00277	0.00434	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—CXCL8—urinary bladder cancer	0.00276	0.00433	CbGpPWpGaD
Chloropyramine—PTK2—Alpha 6 Beta 4 signaling pathway—HRAS—urinary bladder cancer	0.00276	0.00432	CbGpPWpGaD
Chloropyramine—PTK2—Signaling of Hepatocyte Growth Factor Receptor—HRAS—urinary bladder cancer	0.00269	0.00421	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by focal adhesion kinase—CCND1—urinary bladder cancer	0.00268	0.00419	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—CREBBP—urinary bladder cancer	0.00267	0.00419	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—RB1—urinary bladder cancer	0.00266	0.00417	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—SRC—urinary bladder cancer	0.00264	0.00414	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—RHOA—urinary bladder cancer	0.00263	0.00412	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—CNTN2—urinary bladder cancer	0.00263	0.00412	CbGpPWpGaD
Chloropyramine—PTK2—RANKL/RANK Signaling Pathway—SRC—urinary bladder cancer	0.0026	0.00408	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—ERBB2—urinary bladder cancer	0.00257	0.00402	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—RHOA—urinary bladder cancer	0.00253	0.00397	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—MMP9—urinary bladder cancer	0.0025	0.00392	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—TERT—urinary bladder cancer	0.0025	0.00391	CbGpPWpGaD
Chloropyramine—PTK2—Internalization of ErbB1—HRAS—urinary bladder cancer	0.00246	0.00386	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—PRSS3—urinary bladder cancer	0.00244	0.00382	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—RHOA—urinary bladder cancer	0.00242	0.00379	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events regulated by Ret tyrosine kinase—HRAS—urinary bladder cancer	0.00241	0.00378	CbGpPWpGaD
Chloropyramine—PTK2—EPHB forward signaling—HRAS—urinary bladder cancer	0.00241	0.00378	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by focal adhesion kinase—SRC—urinary bladder cancer	0.0024	0.00375	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—MYC—urinary bladder cancer	0.00237	0.00371	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—RHOA—urinary bladder cancer	0.00236	0.00369	CbGpPWpGaD
Chloropyramine—PTK2—Angiopoietin receptor Tie2-mediated signaling—TNF—urinary bladder cancer	0.00234	0.00367	CbGpPWpGaD
Chloropyramine—PTK2—Integrins in angiogenesis—SRC—urinary bladder cancer	0.00233	0.00366	CbGpPWpGaD
Chloropyramine—PTK2—EPHB-mediated forward signaling—HRAS—urinary bladder cancer	0.00232	0.00363	CbGpPWpGaD
Chloropyramine—PTK2—EPH-Ephrin signaling—RHOA—urinary bladder cancer	0.00231	0.00363	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—EGFR—urinary bladder cancer	0.00231	0.00362	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—SRC—urinary bladder cancer	0.0023	0.00361	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—CCND1—urinary bladder cancer	0.00227	0.00355	CbGpPWpGaD
Chloropyramine—PTK2—Primary Focal Segmental Glomerulosclerosis FSGS—CDKN1A—urinary bladder cancer	0.00227	0.00355	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—urinary bladder cancer	0.00224	0.0035	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—FAS—urinary bladder cancer	0.00223	0.0035	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—SRC—urinary bladder cancer	0.00222	0.00348	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by VEGFR1 and VEGFR2—SRC—urinary bladder cancer	0.0022	0.00344	CbGpPWpGaD
Chloropyramine—PTK2—NCAM signaling for neurite out-growth—SRC—urinary bladder cancer	0.0022	0.00344	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—KRAS—urinary bladder cancer	0.00219	0.00342	CbGpPWpGaD
Chloropyramine—PTK2—Caspase Cascade in Apoptosis—TNF—urinary bladder cancer	0.00211	0.00331	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—RHOA—urinary bladder cancer	0.00209	0.00327	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—FGFR3—urinary bladder cancer	0.00208	0.00326	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—CXCL8—urinary bladder cancer	0.00207	0.00324	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—SRC—urinary bladder cancer	0.00203	0.00318	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—EGFR—urinary bladder cancer	0.00202	0.00316	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—MMP9—urinary bladder cancer	0.00201	0.00315	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—MYC—urinary bladder cancer	0.00199	0.00312	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—CCND1—urinary bladder cancer	0.00198	0.0031	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—IL2—urinary bladder cancer	0.00198	0.00309	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—RHOA—urinary bladder cancer	0.00197	0.00309	CbGpPWpGaD
Chloropyramine—PTK2—Cell-Cell communication—CDH1—urinary bladder cancer	0.00196	0.00307	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—CREBBP—urinary bladder cancer	0.00195	0.00305	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—EGFR—urinary bladder cancer	0.00195	0.00305	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—TP53—urinary bladder cancer	0.00194	0.00304	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—SRC—urinary bladder cancer	0.00193	0.00302	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—CDKN1A—urinary bladder cancer	0.00191	0.003	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—PTEN—urinary bladder cancer	0.00191	0.00299	CbGpPWpGaD
Chloropyramine—PTK2—Fcgamma receptor (FCGR) dependent phagocytosis—SRC—urinary bladder cancer	0.00191	0.00299	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—HRAS—urinary bladder cancer	0.00186	0.00291	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—SRC—urinary bladder cancer	0.00185	0.0029	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—KRAS—urinary bladder cancer	0.00184	0.00288	CbGpPWpGaD
Chloropyramine—PTK2—EPH-Ephrin signaling—MMP9—urinary bladder cancer	0.00184	0.00288	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—EP300—urinary bladder cancer	0.00182	0.00285	CbGpPWpGaD
Chloropyramine—PTK2—NCAM signaling for neurite out-growth—KRAS—urinary bladder cancer	0.00182	0.00285	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—SRC—urinary bladder cancer	0.00177	0.00277	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—RHOA—urinary bladder cancer	0.00176	0.00276	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—CDH1—urinary bladder cancer	0.0017	0.00267	CbGpPWpGaD
Chloropyramine—PTK2—EPH-Ephrin signaling—SRC—urinary bladder cancer	0.00169	0.00265	CbGpPWpGaD
Chloropyramine—PTK2—Fc-epsilon receptor I signaling in mast cells—HRAS—urinary bladder cancer	0.00169	0.00264	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—TP53—urinary bladder cancer	0.00164	0.00256	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—BIRC3—urinary bladder cancer	0.00163	0.00255	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—HRAS—urinary bladder cancer	0.00162	0.00254	CbGpPWpGaD
Chloropyramine—PTK2—Integrin-mediated Cell Adhesion—SRC—urinary bladder cancer	0.00161	0.00253	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—RHOA—urinary bladder cancer	0.0016	0.00251	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—urinary bladder cancer	0.00156	0.00245	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—EGFR—urinary bladder cancer	0.00155	0.00243	CbGpPWpGaD
Chloropyramine—PTK2—NCAM signaling for neurite out-growth—HRAS—urinary bladder cancer	0.00155	0.00242	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—SRC—urinary bladder cancer	0.00153	0.00239	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—CCND1—urinary bladder cancer	0.00144	0.00226	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—SRC—urinary bladder cancer	0.00144	0.00226	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—IGF1—urinary bladder cancer	0.00144	0.00225	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—HRAS—urinary bladder cancer	0.00143	0.00224	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—PRSS3—urinary bladder cancer	0.00142	0.00222	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—CDKN1A—urinary bladder cancer	0.0014	0.00219	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—ERBB2—urinary bladder cancer	0.00139	0.00217	CbGpPWpGaD
Chloropyramine—HRH1—IL-4 Signaling Pathway—EP300—urinary bladder cancer	0.00136	0.00213	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—urinary bladder cancer	0.00136	0.00213	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—VHL—urinary bladder cancer	0.00135	0.00212	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—EP300—urinary bladder cancer	0.00133	0.00208	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—RHOA—urinary bladder cancer	0.00132	0.00206	CbGpPWpGaD
Chloropyramine—PTK2—Cell-Cell communication—SRC—urinary bladder cancer	0.00131	0.00205	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—SRC—urinary bladder cancer	0.00129	0.00202	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	0.00128	0.002	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—MT2A—urinary bladder cancer	0.00127	0.00199	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—KRAS—urinary bladder cancer	0.00127	0.00198	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—ERBB2—urinary bladder cancer	0.00122	0.00191	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—KRAS—urinary bladder cancer	0.00119	0.00187	CbGpPWpGaD
Chloropyramine—PTK2—EPH-Ephrin signaling—HRAS—urinary bladder cancer	0.00119	0.00187	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—PTEN—urinary bladder cancer	0.00118	0.00185	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	0.00117	0.00183	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—MYC—urinary bladder cancer	0.00116	0.00181	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—IFNA2—urinary bladder cancer	0.00114	0.00178	CbGpPWpGaD
Chloropyramine—PTK2—Integrin-mediated Cell Adhesion—HRAS—urinary bladder cancer	0.00114	0.00178	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—SRC—urinary bladder cancer	0.0011	0.00172	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—CCND1—urinary bladder cancer	0.00108	0.00169	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—HRAS—urinary bladder cancer	0.00108	0.00168	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—PTEN—urinary bladder cancer	0.00104	0.00163	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—EGFR—urinary bladder cancer	0.00103	0.00161	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—IFNA2—urinary bladder cancer	0.00102	0.0016	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—HRAS—urinary bladder cancer	0.00102	0.00159	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—NCOR1—urinary bladder cancer	0.000986	0.00154	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	0.00098	0.00154	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—KRAS—urinary bladder cancer	0.000971	0.00152	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—S100B—urinary bladder cancer	0.000968	0.00152	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—SRC—urinary bladder cancer	0.000965	0.00151	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—EGFR—urinary bladder cancer	0.000961	0.00151	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—TP53—urinary bladder cancer	0.000951	0.00149	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—TNF—urinary bladder cancer	0.000948	0.00148	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—BIRC3—urinary bladder cancer	0.000947	0.00148	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—KRAS—urinary bladder cancer	0.000908	0.00142	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—HDAC4—urinary bladder cancer	0.000876	0.00137	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—RHOA—urinary bladder cancer	0.00086	0.00135	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	0.000855	0.00134	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—EGFR—urinary bladder cancer	0.000846	0.00132	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—TP53—urinary bladder cancer	0.000836	0.00131	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—PLAU—urinary bladder cancer	0.000807	0.00126	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—ERBB2—urinary bladder cancer	0.000796	0.00125	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—RBX1—urinary bladder cancer	0.000778	0.00122	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—CDK4—urinary bladder cancer	0.000777	0.00122	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—HRAS—urinary bladder cancer	0.000772	0.00121	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—GLI1—urinary bladder cancer	0.000734	0.00115	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—PPARG—urinary bladder cancer	0.000706	0.00111	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—FGFR3—urinary bladder cancer	0.000704	0.0011	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—MMP9—urinary bladder cancer	0.000683	0.00107	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—HRAS—urinary bladder cancer	0.000679	0.00106	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—CREBBP—urinary bladder cancer	0.000679	0.00106	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—CREBBP—urinary bladder cancer	0.000666	0.00104	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—IGF1—urinary bladder cancer	0.000657	0.00103	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—SRC—urinary bladder cancer	0.00063	0.000986	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—RHOA—urinary bladder cancer	0.000614	0.000961	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—RHOA—urinary bladder cancer	0.000602	0.000943	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—CREBBP—urinary bladder cancer	0.000599	0.000939	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—IFNA2—urinary bladder cancer	0.000596	0.000934	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—ERBB2—urinary bladder cancer	0.000568	0.00089	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—S100B—urinary bladder cancer	0.000564	0.000883	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—EGFR—urinary bladder cancer	0.000552	0.000864	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—KRAS—urinary bladder cancer	0.000521	0.000817	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—IL2—urinary bladder cancer	0.000505	0.000791	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—RBX1—urinary bladder cancer	0.000503	0.000788	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—ERBB2—urinary bladder cancer	0.000502	0.000786	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—MMP9—urinary bladder cancer	0.000487	0.000763	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—TSC1—urinary bladder cancer	0.000473	0.000741	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—EP300—urinary bladder cancer	0.000462	0.000724	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—EP300—urinary bladder cancer	0.000453	0.00071	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—JAG1—urinary bladder cancer	0.00045	0.000705	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—SRC—urinary bladder cancer	0.000449	0.000704	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—HRAS—urinary bladder cancer	0.000443	0.000694	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—SRC—urinary bladder cancer	0.000441	0.00069	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—HDAC4—urinary bladder cancer	0.000438	0.000687	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—CDKN1A—urinary bladder cancer	0.000429	0.000672	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—PTEN—urinary bladder cancer	0.000428	0.00067	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—FGFR3—urinary bladder cancer	0.00041	0.000642	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—EP300—urinary bladder cancer	0.000408	0.000639	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—SRC—urinary bladder cancer	0.000397	0.000622	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—EGFR—urinary bladder cancer	0.000394	0.000617	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.000389	0.000609	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	0.000384	0.000601	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—TNF—urinary bladder cancer	0.000375	0.000587	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—KRAS—urinary bladder cancer	0.000372	0.000583	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—GLI1—urinary bladder cancer	0.000367	0.000576	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—KRAS—urinary bladder cancer	0.000365	0.000572	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—S100B—urinary bladder cancer	0.000365	0.000571	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	0.000362	0.000568	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CREBBP—urinary bladder cancer	0.000349	0.000547	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—EGFR—urinary bladder cancer	0.000348	0.000545	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CDH1—urinary bladder cancer	0.000346	0.000543	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—KRAS—urinary bladder cancer	0.000329	0.000515	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—NCOR1—urinary bladder cancer	0.000328	0.000513	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—TP53—urinary bladder cancer	0.000324	0.000508	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—HRAS—urinary bladder cancer	0.000316	0.000495	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—HRAS—urinary bladder cancer	0.00031	0.000486	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	0.000308	0.000483	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000296	0.000464	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—ERBB2—urinary bladder cancer	0.000292	0.000458	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—TERT—urinary bladder cancer	0.000289	0.000452	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—HRAS—urinary bladder cancer	0.000279	0.000437	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—FGFR3—urinary bladder cancer	0.000265	0.000415	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—IL2—urinary bladder cancer	0.000265	0.000415	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—ESR1—urinary bladder cancer	0.000257	0.000403	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—RBX1—urinary bladder cancer	0.000252	0.000394	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CDKN1A—urinary bladder cancer	0.00025	0.000391	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—PTEN—urinary bladder cancer	0.000249	0.00039	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—EP300—urinary bladder cancer	0.000238	0.000372	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—TSC1—urinary bladder cancer	0.000237	0.000371	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—SRC—urinary bladder cancer	0.000231	0.000362	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CREBBP—urinary bladder cancer	0.000226	0.000353	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—JAG1—urinary bladder cancer	0.000225	0.000353	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—IGF1—urinary bladder cancer	0.000223	0.000349	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—RHOA—urinary bladder cancer	0.000204	0.00032	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—EGFR—urinary bladder cancer	0.000203	0.000317	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—KRAS—urinary bladder cancer	0.000191	0.0003	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—RHOA—urinary bladder cancer	0.000191	0.000298	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—ERBB2—urinary bladder cancer	0.000189	0.000296	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—S100B—urinary bladder cancer	0.000183	0.000286	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CXCL8—urinary bladder cancer	0.000179	0.000281	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—RHOA—urinary bladder cancer	0.000173	0.000271	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—IL2—urinary bladder cancer	0.000171	0.000268	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—CXCL8—urinary bladder cancer	0.000167	0.000262	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CCND1—urinary bladder cancer	0.000167	0.000261	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—NCOR1—urinary bladder cancer	0.000164	0.000257	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—HRAS—urinary bladder cancer	0.000163	0.000255	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—MMP9—urinary bladder cancer	0.000162	0.000254	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CDKN1A—urinary bladder cancer	0.000162	0.000253	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—PTEN—urinary bladder cancer	0.000161	0.000252	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—IL2—urinary bladder cancer	0.00016	0.00025	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—EP300—urinary bladder cancer	0.000154	0.000241	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—CXCL8—urinary bladder cancer	0.000152	0.000238	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—SRC—urinary bladder cancer	0.000149	0.000234	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—IL2—urinary bladder cancer	0.000145	0.000227	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—TERT—urinary bladder cancer	0.000145	0.000227	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—MYC—urinary bladder cancer	0.000134	0.00021	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—FGFR3—urinary bladder cancer	0.000133	0.000208	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—EGFR—urinary bladder cancer	0.000131	0.000205	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—ESR1—urinary bladder cancer	0.000129	0.000202	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—KRAS—urinary bladder cancer	0.000124	0.000194	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CREBBP—urinary bladder cancer	0.000113	0.000177	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—IGF1—urinary bladder cancer	0.000112	0.000175	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—EGFR—urinary bladder cancer	0.000111	0.000174	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—TP53—urinary bladder cancer	0.00011	0.000172	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—HRAS—urinary bladder cancer	0.000105	0.000165	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—KRAS—urinary bladder cancer	0.000105	0.000164	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—RHOA—urinary bladder cancer	0.000102	0.00016	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—ERBB2—urinary bladder cancer	9.46e-05	0.000148	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CXCL8—urinary bladder cancer	8.97e-05	0.000141	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—HRAS—urinary bladder cancer	8.92e-05	0.00014	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—IL2—urinary bladder cancer	8.58e-05	0.000134	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CCND1—urinary bladder cancer	8.36e-05	0.000131	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—MMP9—urinary bladder cancer	8.12e-05	0.000127	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CDKN1A—urinary bladder cancer	8.09e-05	0.000127	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—PTEN—urinary bladder cancer	8.07e-05	0.000126	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—EP300—urinary bladder cancer	7.7e-05	0.000121	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—SRC—urinary bladder cancer	7.48e-05	0.000117	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—MYC—urinary bladder cancer	6.71e-05	0.000105	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—EGFR—urinary bladder cancer	6.56e-05	0.000103	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—KRAS—urinary bladder cancer	6.2e-05	9.7e-05	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—TP53—urinary bladder cancer	5.51e-05	8.63e-05	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—HRAS—urinary bladder cancer	5.27e-05	8.25e-05	CbGpPWpGaD
